Production (Stage)
Core Scientific, Inc.
CORZ
$10.68
-$0.15-1.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -28.48% | -9.04% | -9.63% | -34.21% | -42.24% |
| Total Other Revenue | -26.30% | 4.72% | 25.07% | 30.24% | 21.90% |
| Total Revenue | -26.76% | 1.65% | 15.77% | 8.25% | -1.30% |
| Cost of Revenue | -11.40% | -0.41% | -11.39% | -25.33% | -34.53% |
| Gross Profit | -62.28% | 7.97% | 343.01% | 3,223.26% | 667.78% |
| SG&A Expenses | 65.79% | 33.21% | 7.39% | -21.18% | -53.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 229.11% | -64.09% | 1,261.56% | 259.60% | -97.12% |
| Total Operating Expenses | 6.26% | 6.50% | -6.93% | -23.87% | -48.39% |
| Operating Income | -280.59% | -216.96% | 138.91% | 142.61% | 116.41% |
| Income Before Tax | -2,626.93% | -434.63% | -145.54% | 6.70% | 98.01% |
| Income Tax Expenses | 9.30% | 25.77% | 103.88% | 107.54% | 101.32% |
| Earnings from Continuing Operations | -2,568.90% | -433.50% | -156.39% | 5.49% | 97.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2,568.90% | -433.50% | -156.39% | 5.49% | 97.89% |
| EBIT | -280.59% | -216.96% | 138.91% | 142.61% | 116.41% |
| EBITDA | -107.48% | -6.06% | 197.30% | 481.97% | 189.06% |
| EPS Basic | -1,883.23% | -737.95% | -340.37% | -81.68% | 105.68% |
| Normalized Basic EPS | -2,528.89% | -3,274.21% | -2,211.84% | -764.34% | 115.90% |
| EPS Diluted | -4,026.58% | -750.55% | -351.32% | -87.71% | 102.68% |
| Normalized Diluted EPS | -4,172.32% | -3,315.01% | -2,242.97% | -780.08% | 109.94% |
| Average Basic Shares Outstanding | -20.52% | -33.62% | -29.50% | -22.23% | -6.04% |
| Average Diluted Shares Outstanding | -20.02% | -30.23% | -26.15% | -18.82% | -2.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |